GCG and obesity due to melanocortin 4 receptor deficiency: Detailed dietary analysis can be a difficult method to employ in clinical research but it is hoped that future research including larger controlled trials will be possible to examine dietary changes induced by both centrally acting anti-obesity drugs and other potential anti-obesity agents such as glucagon-like-peptide-1 (GLP-1) agonists.